Carbon monoxide and the eye: Implications for glaucoma therapy

Pharmacology and Therapeutics

Volumn 130, Issue 2, 2011, Pages 191-201

  Bucolo, Claudio ^a   Drago, Filippo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Carbon monoxide; Glaucoma; Intraocular pressure

Indexed keywords

CARBON MONOXIDE; HEME; HEME OXYGENASE; HEMIN; HEMOGLOBIN; HYDROGEN SULFIDE; NITRIC OXIDE; PRODRUG;

AIR POLLUTION; BIOLOGICAL ACTIVITY; BLOOD FLOW; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW; SUICIDAL BEHAVIOR;

ANIMALS; CARBON MONOXIDE; CLINICAL TRIALS AS TOPIC; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; EYE; GLAUCOMA; HUMANS; HYDROGEN SULFIDE; INTRAOCULAR PRESSURE; MODELS, BIOLOGICAL; NITRIC OXIDE; OPHTHALMIC SOLUTIONS; REGIONAL BLOOD FLOW;

EID: 79953653858     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.01.013     Document Type: Review

References (117)

1. Abdel Aziz, M. T., Mostafa, T., Atta, H., Wassef, M. A., Fouad, H. H., Rashed, L. A., et al. (2009). Putative role of carbon monoxide signaling pathway in penile erectile function. J Sex Med 6, 49-60.
2. Abraham, N. G., & Kappas, A. (2008). Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60, 79-127. (Pubitemid 351439218)
3. Abraham, N. G., Kushida, T., McClung, J., Weiss, M., Quan, S., Lafaro, R., et al. (2003). Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res 93, 507-514. (Pubitemid 37163230)
4. Allen, T. M., McAllister, L., Mausolf, S., & Gyorffy, E. (1981). Liposome-cell interactions. A study of the interactions of liposomes containing entrapped anti-cancer drugs with the EMT6, S49 and AE1 (transport-deficient) cell lines. Biochim Biophys Acta 643, 346-362.
5. Bathoorn, E., Slebos, D. J., Postma, D. S., Koeter, G. H., van Oosterhout, A. J., van der Toorn, M., et al. (2007). Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J 30, 1131-1137. (Pubitemid 351194760)
6. Beckman, J. S., & Koppenol, W. H. (1996). Nitric oxide, superoxide, and peroxynitrate: the good, the bad, and ugly. Am J Physiol 271, 1424-1437.
7. Biermann, J., Lagrèze, W. A., Dimitriu, C., Stoykow, C., & Goebel, U. (2010). Preconditioning with inhalative carbon monoxide protects rat retinal ganglion cells from ischemia/reperfusion injury. Invest Ophthalmol Vis Sci 51, 3784-3791.
8. Bilban, M., Bach, F., Otterbein, S., Ifedigboe, E., deCosta d'Avila, J., Esterbauer, H., et al. (2006). Carbon monoxide orchestrates a protective response through PPARgamma. Immunity 24, 601-610.
9. Biteman, B., Hassan, I. R., Walker, E., Leedom, A. J., Dunn, M., Seta, F., et al. (2007). Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB J 21, 2257-2266. (Pubitemid 47026460)
10. Boehning, D., & Snyder, S. H. (2003). Novel neural modulators. Annu Rev Neurosci 26, 105-131. (Pubitemid 37064930)
11. Boehning, D., Sedaghat, L., Sedlak, T. W., & Snyder, S. H. (2004). Heme oxygenase-2 is activated by calcium-calmodulin. J Biol Chem 279, 30927-30930. (Pubitemid 39037750)
12. Bolognesi, M., Sacerdoti, D., Piva, A., Di Pascoli, M., Zampieri, F., Quarta, S., et al. (2007). Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats. J Pharmacol Exp Ther 321, 187-194. (Pubitemid 46456973)
13. Botros, F. T., Olszanecki, R., Prieto-Carrasquero, M. C., Goodman, A. I., Navar, L. G., & Abraham, N. G. (2007). Induction of heme oxygenase-1 in renovascular hypertension is associated with inhibition of apoptosis. Cell Mol Biol (Noisy-legrand) 53, 51-60. (Pubitemid 47451193)
14. Brouard, S., Otterbein, L. E., Anrather, J., Tobiasch, E., Bach, F. H., Choi, A. M., et al. (2000). Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192, 1015-1026.
15. Brouard, S., Berberat, P., Tobiasch, E., Seldon, M., Bach, F., & Soares, M. (2002). Heme oxygenase-1-derived carbonmonoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J Biol Chem277, 17950-17961. (Pubitemid 34967606)
16. Campbell, P. I. (1983). Toxicity of some charged lipids used in liposomes preparations. Cytobiosis 37, 21-26.
17. Chang, S. C., Bundgaard, H., Buur, A., & Lee, V. H. L. (1987). Improved corneal penetration of timolol by prodrugs as a means to reduce systemic drug load. Invest Ophthalmol Vis Sci 28, 487-491. (Pubitemid 17040857)
18. Chauveau, C., Bouchet, D., Roussel, J. C., Mathieu, P., Braudeau, C., Renaudin, K., et al. (2002). Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant 2, 581-592. (Pubitemid 36306849)
19. Chin, B., Jiang, G., Wegiel, B., Wang, H., MacDonald, T., Zhang, X., et al. (2007). Hypoxia-inducible factor 1{alpha} stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci USA 104, 5109-5114. (Pubitemid 47186184)
20. Chiou, G. C. Y., Liu, S. X. L., Li, B. H. P., Chiang, C. H., & Varma, R. S. (1995). Ocular hypotensive effects of l-arginine and its derivatives and their actions on ocular blood flow. J Ocul Pharmacol Ther 11, 1-10.
21. Clark, J. E., Naughton, P., Shurey, S., Green, C. J., Johnson, T. R., Mann, B. E., et al. (2003). Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93, 2-8.
22. Conners, M. S., Stoltz, R. A., Dunn, M. W., Abraham, N. G., Levere, R. D., & Laniado- Schwartzman, M. (1995). A closed eye-contact lensmodel of corneal inflammation, II: inhibition of cytochrome P450 arachidonic acid metabolism alleviates inflammatory sequelae. Invest Ophthalmol Vis Sci 36, 841-850.
23. Denninger, J. W., & Marletta, M. A. (1999). Guanylate cyclase and the NO/cGMP signaling pathway. Biochim Biophys Acta 1411, 334-350. (Pubitemid 29221959)
24. Dismuke, W. M., Sharif, N. A., & Ellis, D. Z. (2009). Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel. Invest Ophthalmol Vis Sci 50, 3353-3359.
25. Dong, D. L., Zhang, Y., Lin, D. H., Chen, J., Patschan, S., Goligorsky, M. S., et al. (2007). Carbon monoxide stimulates the Ca2(+)-activated big conductance k channels in cultured human endothelial cells. Hypertension 50, 643-651. (Pubitemid 47447910)
26. Drechsler, Y., Dolganiuc, A., Norkina, O., Romics, L., Li, W., Kodys, K., et al. (2006). Heme oxygenase-1 mediates the anti-inflammatory effects of acute alcohol on IL-10 induction involving p38 MAPK activation in monocytes. J Immunol 177, 2592-2600. (Pubitemid 44201018)
27. Fleischhauer, J. C., Beny, J. L., Flammer, J., & Haefliger, I. O. (2000). NO/cGMP pathway activation and membrane potential depolarization in pig ciliary epithelium. Invest Ophthalmol Vis Sci 41, 1759-1763. (Pubitemid 30354347)
28. Foresti, R., Hoque, M., Bains, S., Green, C. J., & Motterlini, R. (2003). Haem and nitric oxide: synergism in the modulation of the endothelial haem oxygenase-1 pathway. Biochem J 372, 381-390. (Pubitemid 36723883)
29. Foresti, R., Bani-Hani, M. G., & Motterlini, R. (2008). Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med 34, 649-658.
30. Gadalla, M. M., & Snyder, S. H. (2010). Hydrogen sulfide as a gasotransmitter. J Neurochem 113, 14-26.
31. Gasull, X., Ferrer, E., Llobet, A., Castellano, A., Nicolas, J. M., Pales, J., et al. (2003). Cell membrane stretch modulates the high-conductance Ca2+-activated K+ channel in bovine trabecular meshwork cells. Invest Ophthalmol Vis Sci 44, 706-714. (Pubitemid 36159718)
32. Giuffrida, S., Bucolo, C., & Drago, F. (2003). Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma. J Ocul Pharmacol 19, 527-534. (Pubitemid 38030239)
33. Guo, Y., Stein, A. B., Wu, W. J., Tan, W., Zhu, X., Li, Q. H., et al. (2004). Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 286, 1649-1653.
34. Haefliger, I. O., Dettmann, E., Liu, R., Meyer, P., Prünte, C., Messerli, J., et al. (1999a). Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma. Surv Ophthalmol 43, 51-58.
35. Haefliger, I. O., Dettmann, E., Liu, R., Meyer, P., Prünte, C., Messerli, J., et al. (1999b). Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma. Surv Ophthalmol 43, 51-58.
36. Haider, A., Olszanecki, R., Gryglewski, R., Schwartzman, M. L., Lianos, E., Kappas, A., et al. (2002). Regulation of cyclooxygenase by the heme-heme oxygenase system in microvessel endothelial cells. J Pharmacol Exp Ther 300, 188-194. (Pubitemid 34028526)
37. Hanneken, A., Lin, F. F., Johnson, J., & Maher, P. (2006). Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. Invest Ophthalmol Vis Sci 47, 3164-3177. (Pubitemid 351639797)
38. Jaggar, J. H., Leffler, C. W., Cheranov, S. Y., Tcheranova, D., & Cheng, X. (2002). Carbon monoxide dilates cerebral arteriole by enhancing the coupling of Ca2+ sparks to Ca2+-activated K+ channels. Circ Res 91, 610-617.
39. Jaggar, J. H., Li, A., Parfenova, H., Liu, J., Umstot, E. S., Dopico, A. M., et al. (2005). Heme is a carbon monoxide receptor for large-conductance Ca2+-activated K channels. Circ Res 97, 805-812. (Pubitemid 41447131)
40. Joshi, A. (1994). Microparticulates for ophthalmic drug delivery. J Ocul Pharmacol 10, 29-45.
41. Kajimura, M., Shimoyama, M., Tsuyama, T., Suzuki, T., Kozaki, S., Takenaka, S., et al. (2003). Visualization of gaseous monoxide reception by soluble guanylate cyclase in the rat retina. FASEB J 17, 506-508.
42. Kiel, J. W., & van Heuven, W. A. (1995). Ocular perfusion pressure and choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci 36, 579-585.
43. Kiel, J. W., Reitsamer, H. A., Walker, J. S., & Kiel, F. W. (2001). Effects of nitric oxide synthase inhibition on ciliary blood flow, aqueous production and intraocular pressure. Exp Eye Res 73, 355-364. (Pubitemid 32977201)
44. Kim, H. P., Ryter, S. W., & Choi, A. M. (2006). CO as a cellular signaling molecule. Annu Rev Pharmacol Toxicol 46, 411-449. (Pubitemid 43271196)
45. Kimura, H., Nagai, Y., Umenura, K., & Kimura, Y. (2005). Physiological roles of hydrogen sulfide: synaptic modulation, neuroprotection, and smooth muscle relaxation. Antioxid Redox Signal 7, 795-803. (Pubitemid 40563221)
46. Kotikoski, H., Vapaatalo, H., & Oksala, O. (2003). Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits. Curr Eye Res 26, 119-123. (Pubitemid 36776119)
47. Kourembanas, S. (2002). Hypoxia and carbon monoxide in the vasculature. Antioxid Redox Signal 4, 291-299.
48. Krupin, T., Weiss, A., Becker, B., Holmberg, N., & Fritz, C. (1997). Increased intraocular pressure following topical azide or nitroprusside. Invest Ophthalmol Vis Sci 16, 1002-1007.
49. Laniado Schwartzman, M., Abraham, N. G., Conners, M. S., Dunn, M. W., Levere, R. D., & Kappas, A. (1997). Heme oxygenase induction with attenuation of experimentally-induced corneal inflammation. Biochem Pharmacol 53, 1069-1075. (Pubitemid 27224252)
50. Lee, T. S., & Chau, L. Y. (2002). Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 8, 240-246.
51. Lee, V. H. L., & Robinson, J. R. (1986). Topical ocular drug delivery: recent development and future challenges. J Ocul Pharmacol 2, 67-108. (Pubitemid 17193813)
52. Lee, Y. C., Martin, E., & Murad, F. (2000). Human recombinant soluble guanylyl cyclase: expression, purification, and regulation. Proc Natl Acad Sci USA 97, 10763-10768.
53. Lefer, D. J. (2007). A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulphide. Proc Natl Acad Sci 104, 17907-17908.
54. Li Volti, G., Seta, F., Schwartzman, M. L., Nasjletti, A., & Abraham, N. G. (2003). Heme oxygenase attenuates angiotensin II-mediated increase in cyclooxygenase-2 activity in human femoral endothelial cells. Hypertension 41, 715-719. (Pubitemid 36314580)
55. Liu, R., Flammer, J., & Haeflinger, I. O. (1999). Isoproterenol, forskolin, and cAMP-induced nitric oxide production in pig ciliary processes. Invest Ophthalmol Vis Sci 40, 1833-1837. (Pubitemid 29297163)
56. Macha, S., Mitra, A. K., & Hughes, P. M. (2003). Overview of ocular drug delivery. In A. K. Mitra (Ed.), Ophthalmic drug delivery systems (pp. 1-12). New York: Marcel Dekker, Inc..
57. Maher, P., & Hanneken, A. (2005). Flavonoids protect retinal ganglion cells from oxidative stress-induced death. Invest Ophthalmol Vis Sci 46, 4796-4803. (Pubitemid 44264586)
58. Martin, E., Davis, K., Bian, K., Lee, Y. C., & Murad, F. (2000). Cellular signaling with nitric oxide and cyclic guanosine monophosphate. Semin Perinatol 24, 2-6. (Pubitemid 30115261)
59. Masini, E., Vannacci, A., Failli, P., Mastroianni, R., Giannini, L., Vinci, M. C., et al. (2008). A carbon monoxide-releasing molecule (CORM-3) abrogates polymorphonuclear granulocyte-induced activation of endothelial cells and mast cells. FASEB J 22, 3380-3388.
60. Maurice, D. M., & Mishima, S. (1984). Ocular pharmacokinetics. In M. L. Sears (Ed.), Pharmacology of the eye (pp. 19-116). Berlin: Spring-Verlag.
61. Mayer, P., Champion, C., Schlotzer-Schrehardt, U., Flammer, J., & Haefliger, I. O. (1999). Localization of nitric oxide synthase isoforms in porcine ocular tissues. Curr Eye Res 18, 375-380. (Pubitemid 29237881)
62. Milbury, P. E., Graf, B., Curran-Celentano, J. M., & Blumberg, J. B. (2007). Bilberry (vaccinium myrtillus) anthocyanins modulate heme oxygenase-1 and glutathione S-transferase-pi expression in ARPE-19 cells. Invest Ophthalmol Vis Sci 48, 2343-2349. (Pubitemid 351261315)
63. Minamino, T., Christou, H., Hsieh, C. M., Liu, Y., Dhawan, V., Abraham, N. G., et al. (2001). Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci USA 98, 8798-8803. (Pubitemid 32678107)
64. Mishima, S. (1981). Clinical pharmacokinetics of the eye. Invest Ophthalmol Vis Sci 21, 504-511.
65. Morse, D., Pischke, S. E., Zhou, Z., Davis, R. J., Flavell, R. A., Loop, T., et al. (2003). Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem 278, 36993-36998. (Pubitemid 37175212)
66. Motterlini, R., Mann, B. E., Johnson, T., Clark, J., Foresti, R., & Green, C. (2003). Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr Pharm Des 9, 2525-2539. (Pubitemid 37236371)
67. Murad, F. (2008). Nitric oxide and cyclic guanosine monophosphate signaling in the eye. Can J Ophthalmol 43, 291-294.
68. Nathanson, J. A., & McKee, M. (1995). Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye. Invest Ophthalmol Vis Sci 36, 1765-1773.
69. Nemesure, B., Honkanen, R., Hennis, A., Wu, S. Y., & Leske, M. C. (2007). Barbados eye studies group. Incident open-angle glaucoma and intraocular pressure. Ophthalmology 114, 1810-1815.
70. Neufeld, A. H., Sawada, A., & Becker, B. (1999). Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA 96, 9944-9948. (Pubitemid 29398837)
71. Neufeld, A. H., Das, S., Vaora, S., Gachie, E., Kawai, S., Manning, P. T., et al. (2002). A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma. J Glaucoma 11, 221-225. (Pubitemid 34620098)
72. Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., et al. (2000). Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6, 422-428. (Pubitemid 30208159)
73. Otterbein, L. E., Zuckerbraun, B., Haga, M., Liu, F., Song, R., Usheva, A., et al. (2003a). Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9, 183-190. (Pubitemid 36227720)
74. Otterbein, L. E., Otterbein, S., Ifedigbo, E., Liu, F., Morse, D., Fearns, C., et al. (2003b). MKK3 mitogen-activated protein kinase pathway mediates carbon monoxide-induced protection against oxidant-induced lung injury. Am J Pathol 163, 2555-2563. (Pubitemid 37466496)
75. Paine, A., Eiz-Vesper, B., Blasczyk, R., & Immenschuh, S. (2010). Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 80, 1895-1903.
76. Parker, J. D. (2003). Therapy with nitrates: increasing evidence of vascular toxicity? J Am Coll Cardiol 42, 1835-1837.
77. Patil, K., Bellner, L., Cullaro, G., Gotlinger, K. H., Dunn, M. W., & Schwartzman, M. L. (2008). Heme oxygenase-1 induction attenuates corneal inflammation and accelerates wound healing after epithelial injury. Invest Ophthalmol Vis Sci 49, 3379-3386.
78. Pong, W. W., & Eldred, W. D. (2009). Interactions of the gaseous neuromodulators nitric oxide, carbon monoxide, and hydrogen sulfide in the salamander retina. J Neurosci Res 87, 2356-2364.
79. Poss, K. D., & Tonegawa, S. (1997). Reduced stress defense in haemoxygenase 1-deficient cells. Proc Natl Acad Sci USA 94, 10925-10930. (Pubitemid 27430837)
80. Privitera, M. G., Potenza, M., Bucolo, C., & Drago, F. (2007). Hemin, an inducer of heme oxygenase-1, lowers intraocular pressure in rabbits. J Ocul Pharmacol Ther 23, 232-239. (Pubitemid 46986603)
81. Resch, H., Zawinka, C., Weigert, G., Schmetterer, L., & Garhöfer, G. (2005). Inhaled carbon monoxide increases retinal and choroidal blood flow in healthy humans. Invest Ophthalmol Vis Sci 46, 4275-4280. (Pubitemid 44264632)
82. Rodella, L., Lamon, B. D., Rezzani, R., Sangras, B., Goodman, A. I., Falck, J. R., et al. (2006). Carbon monoxide and biliverdin prevent endothelial cell sloughing in rats with type I diabetes. Free Radic Biol Med 40, 2198-2205. (Pubitemid 43903106)
83. Rodgers, P. A., Vreman, H. J., Dennery, P. A., & Stevenson, D. K. (1994). Sources of carbon monoxide (CO) in biological systems and applications of CO detection technologies. Semin Perinatol 18, 2-10. (Pubitemid 24064618)
84. Ryter, S. W., Alam, J., & Choi, A. M. (2006). Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86, 583-650.
85. Sarady, J., Otterbein, S., Liu, F., Otterbein, L. E., & Choi, A. (2002). Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am J Respir Cell Mol Biol 27, 739-745. (Pubitemid 35381183)
86. Sarady-Andrews, J., Liu, F., Gallo, D., Nakao, A., Overhaus, M., Ollinger, R., Choi, A. M., & Otterbein, L. E. (2005). Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 289, 1131-1137.
87. Sato, K., Balla, J., Otterbein, L., Smith, R., Brousar, S., Lin, Y., et al. (2001). Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166, 4185-4194. (Pubitemid 32224952)
88. Sawle, P., Foresti, R., Mann, B. E., Johnson, T. R., Green, C. J., & Motterlini, R. (2005). Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 145, 800-810. (Pubitemid 41076287)
89. Schaer, C. A., Schoedon, G., Imhof, A., Kurrer, M. O., & Schaer, D. J. (2006). Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circ Res 99, 943-950. (Pubitemid 44657797)
90. Sjostrand, T. (1970). Early studies of CO production. Ann NY Acad Sci 174, 5-10.
91. Snyder, S. H., Jaffrey, S. R., & Zakhary, R. (1998). Nitric oxide and carbon monoxide: parallel roles as neural messengers. Brain Res Brain Res Rev 26, 167-175. (Pubitemid 28318073)
92. Song, R., Kubo, M., Morse, D., Zhou, Z., Zhang, X., Dauber, J. H., et al. (2003). Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol 163, 231-242. (Pubitemid 36759607)
93. Stagni, E., Privitera, M. G., Bucolo, C., & Drago, F. (2009). A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits. Br J Ophthalmol 93, 254-257.
94. Stone, J. R., & Marletta, M. A. (1994). Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 33, 5636-5640. (Pubitemid 24163003)
95. Stumpff, F., & Wiederholt, M. (2000). Regulation of trabecular meshwork contractility. Ophthalmologica 214, 33-53. (Pubitemid 30084879)
96. Szabo, M. E., Gallyas, E., Bak, I., Rakotovao, A., Boucher, F., de Leiris, J., et al. (2004). Heme oxygenase-1-related carbon monoxide and flavonoids in ischemic-reperfused rat retina. Invest Ophthalmol Vis Sci 45, 3727-3732. (Pubitemid 39298591)
97. Taille, C., El-Benna, J., Lanone, S., Boczkowski, J., & Motterlini, R. (2005). Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem 280, 25350-25360. (Pubitemid 40962237)
98. Taniguchi, T., Kawakami, H., Sawada, A., Iwaki, M., Tsuji, A., Sugiyama, K., et al. (1998). Effects of nitric oxide synthase inhibitor on intraocular pressure and ocular inflammation following laser irradiation in rabbits. Curr Eye Res 17, 308-315. (Pubitemid 28138279)
99. Tsai, D. C., Hsu, W. M., Chou, C. K., Chen, S. J., Peng, C. H., Chi, C. W., et al. (2002). Significant variation of the elevated nitric oxide levels in aqueous humor from patients with different types of glaucoma. Ophthalmologica 216, 346-350.
100. Varadi, J., Lekli, I., Juhasz, B., Bacskay, I., Szabo, G., Gesztelyi, R., et al. (2007). Beneficial effects of carbon monoxide releasing molecules on post-ischemic myocardial recovery. Life Sci 80, 1619-1626. (Pubitemid 46412364)
101. Verma, A., Hirsch, D. J., Glatt, C. E., Ronnett, G. V., & Snyder, S. H. (1993). Carbon monoxide: a putative neural messanger. Science 259, 381-384. (Pubitemid 23055683)
102. Wagener, F., Volk, H., Willis, D., Abraham, N., Soares, M., Adema, G., et al. (2003). Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 55, 551-571. (Pubitemid 37013215)
103. Wang, R., & Wu, L. (1997). The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem 272, 8222-8226. (Pubitemid 27147775)
104. Wang, R., Wu, L., & Wang, Z. (1997). The direct effect of carbon monoxide on KCa in vascular smooth muscle cells. Pflugers Arch 434, 285-291. (Pubitemid 27276232)
105. Wiederholt, M., Thieme, H., & Stumpff, F. (2000). The regulation of trabecular meshwork and ciliary muscle contractility. Prog Retin Eye Res 19, 271-295. (Pubitemid 30122724)
106. Willis, D., Tomlinson, A., Frederick, R., Paul-Clark, M. J., & Willoughby, D. A. (1995). Modulation of heme oxygenase activity in rat brain and spleen by inhibitors and donors of nitric oxide. Biochem Biophys Res Commun 214, 1152-1156.
107. Worakul, N., & Robinson, J. R. (1997). Ocular pharmacokinetics/ pharmacodynamics. Eur J Pharm Biopharm 44, 71-75.
108. Xi, Q., Tcheranova, D., Parfenova, H., Horowitz, B., Leffler, C. W., & Jaggar, J. H. (2003). Carbon monoxide activates KCa channel in newborn arteriole smooth muscle cells by increasing apparent Ca2+ sensitivity of alpha-subunit. Am J Physiol Heart Circ Physiol 4, 286-289.
109. Yachie, A., Niida, Y., Wada, T., Igarashi, N., Kaneda, H., Toma, T., et al. (1999). Oxidative stress causes enhanced endothelial cell injury inhuman hemeoxygenase-1deficiency. J Clin Invest 103, 129-135. (Pubitemid 29031171)
110. Yoshihara, E., & Nakae, T. (1986). Cytolitic activity of liposomes containing stearylamine. Biochim Biophys Acta 854, 93-101. (Pubitemid 16165481)
111. Yucel, I., Akar, Y., Yucel, G., Ciftcioglu, M. A., Keles, N., & Aslan, M. (2005). Effect of hypercholesterolemia on inducible nitric oxide synthase expression in a rat model of elevated intraocular pressure. Vision Res 45, 1107-1114. (Pubitemid 40222388)
112. Zamora, D. O., & Kiel, J. W. (2010). Episcleral venous pressure responses to topical nitroprusside and N-nitro-L-arginine methyl ester. Invest Ophthalmol Vis Sci 51, 1614-1620.
113. Zhang, H., & Bhatia, M. (2008). Hydrogen sulfide: a novel mediator of leukocyte activation. Immunopharmacol Immunotoxicol 30, 631-645.
114. Zhang, X., Shan, P., Alam, J., Fu, X., & Lee, P. (2005). Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/ Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury. J Biol Chem280, 8714-8721. (Pubitemid 40409558)
115. Zhang, X., Shan, P., Jiang, G., Zhang, S., Otterbein, L. E., Fu, X., et al. (2006). Endothelial STAT3 is essential for the protective effects of HO-1 in oxidant-induced lung injury. FASEB J 20, 2156-2158.
116. Zuckerbraun, B., Billiar, T., Otterbein, S., Kim, P., Liu, F., Choi, A., et al. (2003). Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J Exp Med 198, 1707-1716. (Pubitemid 37494163)
117. Zuckerbraun, S., Chin, B., Wegiel, B., Billiar, T., Csizmadia, E., Rao, J., et al. (2006). Carbon monoxide reverses established pulmonary hypertension. J Exp Med 203, 2109-2119. (Pubitemid 44352232)